Nuveen Asset Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-61	Closed	-$210K	–	3440
2022 Q1	$210K	Buy	61 +1	+2%	+$3.44K	﹤0.01%	3183
2021 Q4	$355K	Sell	60 -10	-14%	-$59.2K	﹤0.01%	3139
2021 Q3	$536K	Buy	70 +28	+67%	+$214K	﹤0.01%	3157
2021 Q2	$429K	Buy	+42	New	+$429K	﹤0.01%	3182